About
Immunique develops immune cell platform technologies including NK cell and regulatory T cell (Treg) therapies and AI-designed cytokine-like peptides aimed at enhancing immune resilience for improved recovery and healthy aging.
Explore Immunique's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.